1. Home
  2. CDNA vs BHC Comparison

CDNA vs BHC Comparison

Compare CDNA & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$78.26

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Logo Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc.

N/A

Current Price

$8.34

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNA
BHC
Founded
1998
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
CDNA
BHC
Price
$78.26
$8.34
Analyst Decision
Buy
Hold
Analyst Count
8
7
Target Price
★ $94.43
$8.40
AVG Volume (30 Days)
1.3M
★ 3.9M
Earning Date
10-29-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 423.08
EPS
★ 2.45
N/A
Revenue
$48,324,000.00
★ $8,724,000,000.00
Revenue This Year
$38.18
$7.43
Revenue Next Year
$8.98
N/A
P/E Ratio
$32.57
★ N/A
Revenue Growth
★ 18.93
N/A
52 Week Low
$15.15
$4.33
52 Week High
$90.87
$9.04

Technical Indicators

Market Signals
Indicator
CDNA
BHC
Relative Strength Index (RSI) 55.14 66.03
Support Level $17.15 $7.86
Resistance Level $90.87 N/A
Average True Range (ATR) 5.25 0.43
MACD -0.64 0.03
Stochastic Oscillator 43.11 74.96

Price Performance

Historical Comparison
CDNA
BHC

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

Share on Social Networks: